Literature DB >> 33199221

Major fall in urgent skin cancer referrals during the COVID-19 outbreak.

Harvey Rich1, Tomas O'Neill2.   

Abstract

The SARS-CoV-2 cornovirus disease (COVID-19) pandemic has significantly affected referrals of new suspected cancers from primary care to specialist services in the National Health Service (NHS) across the UK.  Amongst the many factors causing delay, such as fear and uncertainty about COVID-19 transmission, reluctance to seek medical attention for cancer sypmtoms and avoiding additional pressure on NHS services, we anticipate a surge in urgent skin cancer referrals to our plastic surgery service as we enter a post-COVID recovery phase.  On the basis of previous referral data and statistical forecasting, we share our predicted numbers against our actual number of urgent skin cancer referrals for the COVID-19 period and, based on this analysis, encourage all cancer services to prepare and allocate resources appropriately for the busy months to follow.
Copyright © 2020 British Association of Plastic, Reconstructive and Aesthetic Surgeons. Published by Elsevier Ltd. All rights reserved.

Entities:  

Year:  2020        PMID: 33199221      PMCID: PMC7649036          DOI: 10.1016/j.bjps.2020.10.087

Source DB:  PubMed          Journal:  J Plast Reconstr Aesthet Surg        ISSN: 1748-6815            Impact factor:   2.740


  2 in total

1.  Cancer care under the outbreak of COVID-19: A perspective from Italian tertiary referral center for surgical oncology.

Authors:  Luigi Marano; Daniele Marrelli; Franco Roviello
Journal:  Eur J Surg Oncol       Date:  2020-04-15       Impact factor: 4.424

2.  Reduction in skin cancer diagnosis, and overall cancer referrals, during the COVID-19 pandemic.

Authors:  C H Earnshaw; H J A Hunter; E McMullen; C E M Griffiths; R B Warren
Journal:  Br J Dermatol       Date:  2020-10       Impact factor: 11.113

  2 in total
  4 in total

Review 1.  Implementation of a telemedicine service to provide skin cancer care in a tertiary plastic surgery unit during COVID-19 - a comprehensive review.

Authors:  Molly Jakeman; Rong Khaw; Shomari Zack-Williams; Philip Brackley
Journal:  J Plast Reconstr Aesthet Surg       Date:  2022-04-25       Impact factor: 3.022

2.  COVID-19 and the Surveillance, Epidemiology, and End Results Program: Future considerations for skin cancer research.

Authors:  David X Zheng; Christopher R Cullison; Kathleen M Mulligan; Jeffrey F Scott
Journal:  J Plast Reconstr Aesthet Surg       Date:  2021-03-31       Impact factor: 2.740

3.  Impact of COVID-19 pandemic on diagnostic pathology in the Netherlands.

Authors:  M L F van Velthuysen; S van Eeden; S le Cessie; M de Boer; H van Boven; B M Koomen; F Roozekrans; J Bart; W Timens; Q J M Voorham
Journal:  BMC Health Serv Res       Date:  2022-02-09       Impact factor: 2.655

4.  The impact of treatment delay on skin cancer in COVID-19 era: a case-control study.

Authors:  Konstantinos Seretis; Eleni Boptsi; Anastasia Boptsi; Efstathios G Lykoudis
Journal:  World J Surg Oncol       Date:  2021-12-24       Impact factor: 2.754

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.